Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365619
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-04-09
Brief Title:
Neoadjuvant IpilimumabNivolumab for Patients With Recurrent High Risk Resectable Melanoma
Sponsor:
University of Utah
Organization:
University of Utah
Organization Data
Organization:
University of Utah
Class:
OTHER
Study ID:
HCI168525
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Utah
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None